News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AusAm Biotechnologies's Accumin Urine Albumin Test Receives Expanded Indications For Use For Those At-Risk For Heart Disease Complications


10/19/2005 5:12:25 PM

AusAm Biotechnologies, Inc. today announced that Accumin(TM) has received expanded labeling to its 510(k) from the U.S. Food and Drug Administration (FDA) for "diagnostic use in quantitation of intact albumin in urine from patients with cardiovascular diseases associated with increased albumin levels."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES